Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Cooper

Showing results (211-220 of 246) with videos related to

Pageof 25
Sort By:
American Journal of Medical Genetics|May 9, 2001
Case/control family study of autonomic nervous system dysfunction in idiopathic congenital central hypoventilation syndromeD E Weese-Mayer, J M Silvestri, A D Huffman, et al.
Kidney International|September 30, 2000
Osteopontin expression in progressive renal injury in remnant kidney: role of angiotensin IIX Q Yu, L L Wu, X R Huang, et al.
The Journal of Clinical Investigation|December 19, 2001
Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE)M D Oldfield, L A Bach, J M Forbes, et al.
Orthodontics & Craniofacial Research|August 27, 2002
Cleft lip with or without cleft palate and dermatoglyphic asymmetry: evaluation of a Chinese populationK Neiswanger, M E Cooper, S M Weinberg, et al.
Diabetes|October 27, 1999
Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetesM E Cooper, D Vranes, S Youssef, et al.
Diabetologia|October 29, 2009
The endothelin receptor antagonist avosentan ameliorates nephropathy and atherosclerosis in diabetic apolipoprotein E knockout miceA M D Watson, J Li, C Schumacher, et al.
Ugeskrift for Laeger|October 17, 2001
[Effect of losartan on renal and cardiovascular complications of patients with type 2 diabetes and nephropathy]H H Parving, B M Brenner, M E Cooper, et al.
The New England Journal of Medicine|September 22, 2001
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathyB M Brenner, M E Cooper, D de Zeeuw, et al.
Diabetologia|October 8, 2005
Polymorphisms in the gene encoding angiotensin I converting enzyme 2 and diabetic nephropathyS Fröjdö, L Sjölind, M Parkkonen, et al.
Kidney International|October 10, 1998
Renal expression of transforming growth factor-beta inducible gene-h3 (beta ig-h3) in normal and diabetic ratsR E Gilbert, J L Wilkinson-Berka, D W Johnson, et al.
Pageof 25

Showing results (211-220 of 246) with videos related to

Sort By:
Pageof 25
American Journal of Medical Genetics|May 9, 2001
Case/control family study of autonomic nervous system dysfunction in idiopathic congenital central hypoventilation syndromeD E Weese-Mayer, J M Silvestri, A D Huffman, et al.
Kidney International|September 30, 2000
Osteopontin expression in progressive renal injury in remnant kidney: role of angiotensin IIX Q Yu, L L Wu, X R Huang, et al.
The Journal of Clinical Investigation|December 19, 2001
Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE)M D Oldfield, L A Bach, J M Forbes, et al.
Orthodontics & Craniofacial Research|August 27, 2002
Cleft lip with or without cleft palate and dermatoglyphic asymmetry: evaluation of a Chinese populationK Neiswanger, M E Cooper, S M Weinberg, et al.
Diabetes|October 27, 1999
Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetesM E Cooper, D Vranes, S Youssef, et al.
Diabetologia|October 29, 2009
The endothelin receptor antagonist avosentan ameliorates nephropathy and atherosclerosis in diabetic apolipoprotein E knockout miceA M D Watson, J Li, C Schumacher, et al.
Ugeskrift for Laeger|October 17, 2001
[Effect of losartan on renal and cardiovascular complications of patients with type 2 diabetes and nephropathy]H H Parving, B M Brenner, M E Cooper, et al.
The New England Journal of Medicine|September 22, 2001
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathyB M Brenner, M E Cooper, D de Zeeuw, et al.
Diabetologia|October 8, 2005
Polymorphisms in the gene encoding angiotensin I converting enzyme 2 and diabetic nephropathyS Fröjdö, L Sjölind, M Parkkonen, et al.
Kidney International|October 10, 1998
Renal expression of transforming growth factor-beta inducible gene-h3 (beta ig-h3) in normal and diabetic ratsR E Gilbert, J L Wilkinson-Berka, D W Johnson, et al.
Pageof 25